Jingwen Dong
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targeting GRP75 by natural compound polyphyllin II triggers mitochondrial calcium overload and pyroptosis to potentiate cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: June 03, 2026
Pulsatilla saponin D triggers SHP2-mediated mitochondrial dysfunction and ferroptosis to augment cancer immunotherapy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 23, 2026
Pathogen-Centric Activation of an Azoreductase-Responsive Antibody-Antibiotic Conjugate for the Targeted Eradication of MRSA.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 22, 2026
Publisher Correction: Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins.
Journal: Nature chemical biology
Published: June 26, 2025
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1.
Journal: Research (Washington, D.C.)
Published: April 24, 2025
Novel Quaternary Ammonium Salt-Linked STING Agonist Antibody-Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off-Target Toxicity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 06, 2025
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents.
Journal: Journal of medicinal chemistry
Published: December 28, 2024
Azobenzene-Based Linker Strategy for Selective Activation of Antibody-Drug Conjugates.
Journal: Angewandte Chemie (International ed. in English)
Published: July 20, 2023
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins.
Journal: Nature chemical biology
Published: July 08, 2023
Evaluation and mechanism study of Pien Tze Huang against EV-A71 infection.
Journal: Frontiers in pharmacology
Published: July 02, 2023
USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1.
Journal: Cell death and differentiation
Published: January 11, 2023
Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment.
Journal: Journal of medicinal chemistry
Published: December 29, 2022
Last Updated: 09/26/2026